Aeglea BioTherapeutics Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Aeglea BioTherapeutics (AGLE) IPO Opens Flat
April 7, 2016 10:55 AM EDTToday's IPO for Aeglea BioTherapeutics (NASDQ: AGLE) opened for trading at $10 after pricing 5,000,000 shares of its common stock at an initial public offering price of $10 per share.
UBS Investment Bank, BMO Capital Markets and Wells Fargo Securities are acting as joint book-running managers... More
